Healthcare costs of invasive meningococcal disease: a nationwide population-based study using an innovative clustering method to identify sequelae

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> : Cost-of-illness studies for invasive meningococcal disease (IMD) are scarce, mainly because the disease is rare, its prognosis varies widely, and some sequelae can develop far from the acute phase. We conducted a retrospective longitudinal cohort study to estimate the healthcare costs associated with IMD in France, in the short (1 month), medium (2 years), a...

Topics

Open a Topic to create a Post that cites this publication.

• Cost of Illness
• Epidemics
• France
• Meningococcal Infections
• Meningococcal Vaccines
• Neisseria meningitidis
• Neisseria meningitidis, Serogroup B
• Vaccination

Identifiers and source

Literature Corpus work

f45420f8-6692-53be-9463-43981e219550

DOI

10.21203/rs.3.rs-6453754/v1